Nucleic Acid Complexes with Cationic/Anionic Polymers and RNA Molecules

The USPTO published a patent application disclosing nucleic acid complexes comprising cationic polymers, anionic polymers, and monomeric RNA molecules. The disclosed invention describes complexes where a cationic polymer and RNA molecule form a core complex that is encapsulated by an anionic polymer, with both linear and non-linear configurations covered. CPC classifications indicate applications in pharmaceutical formulations, drug delivery, and therapeutic RNA technologies.

For pharmaceutical companies and biotech firms developing RNA-based therapeutics or drug delivery systems, this patent application represents potential IP that could affect freedom-to-operate analysis. Parties conducting research in nucleic acid delivery, polymer-based encapsulation, or mRNA formulation should monitor the prosecution of this application to assess potential licensing needs or design-around considerations.